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ABST RACT
Breast cancer patients are vulnerable to elevated stress related to receiving
the diagnosis, unfamiliar and invasive treatment, and coping with the sideeffects of treatment, which may find various forms of expression. Another
common feature of this patient population is body image dysphoria. Both the
disease and treatment lead to impairments in physical appearance and
general bodily functioning. This study aimed to explore the differen tial
manifestations of stress and the nature of body image dysphoria within a
sample of female breast cancer patients (n=80), compared to female patients
with other sites of disease (n=80) in order to examine differences in the
experiences of distress in these groups. Patients completed 4 questionnaires
relating to psychological distress and body image dysphoria. The results
showed the breast patients reported significantly higher levels of body image
dysphoria and reflected differential indicators of stress, namely more
psychological and behavioral expression, as compared to the other group.

Introduction
Breast cancer is the most frequent cancer in women and
is the second most common cancer in general. More than 2
million new diagnoses worldwide were reported in 2018
[1]. While rates of breast cancer have been higher among
women in developed regions of the world, rates are rising
nearly everywhere [2]. Cancer survival has improved since
the mid‐1970s largely due to improvements in detection
practices and the increased use of adjuvant systemic
therapies, inter alia newer cytotoxic drugs, adjuvant
hormonal therapy and biologics, in addition to regional
radiotherapy [3,4]. Due to these advances, a growing
number of cancer patients will become long-term
survivors, living with the physiological and psychological
effects of their disease and treatment [5].
A cancer diagnosis is an important source of
psychological distress and is followed by an extended
interval of treatment which in itself is also experienced as
stressful [6]. Studies indicate that women with breast
cancer are among the most distressed of the subgroups of
cancer diagnoses and report distress related to fear of
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disease progression and recurrence. This distress may
manifest as depressed mood, stress, and elevated anxiety
relating to prognosis, disability, and death [7].
Previous studies suggest that psychological disorders
negatively affect treatment, cancer progression, and
outcomes, and thus exert a significant effect on morbidity
and mortality [8,9]. As such, the importance of the patient’s
psychological well-being cannot be overstated. A key goal
in breast cancer therapy is to improve the support of the
growing numbers of women diagnosed with the disease to
facilitate adjustment into survivorship in the long-term [5].
Breast cancer research has historically concentrated on
both the physical and mental health sequelae of cancer and
its treatment, but commonly health care providers tend to
focus chiefly on patients’ physical symptoms, and place
less emphasis on mental health [5]. Stress and the well
documented insults to body image faced by patients are
common features of the psychological distress which these
patients experience, which negatively impacts the patient’s
ability to adjust after cancer and into survivorship [10].
This research follows on and expands on a previous
study [11], and goes on to explore the aetiology of
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psychological distress in these patients in more detail.
Further facets of body image disturbances and the
complexity of body image responses to breast disease are
examined and useful therapeutic interventions are
discussed.
Cancer-specific stress disorders in breast patients
In the context of this study, stress is defined generally
as a multidimensional construct referring to an individual’s
response to external conditions and more subjectively, as
the response to the appraisal of these demands, which is
mediated by one’s coping skills [12].
The human stress response may be conceptualized as
both physiologically- and psychologically- based. In terms
of physiology, both acute and chronic stress following a
life event such as the diagnosis of cancer have implications
for the disruption of various neurotransmitters and
neurohormones. Neurotransmitters impact both the
physical and psychological functioning of the individual
experiencing stress. In psychological terms, problems with
the cognitive processing of a stressor may precipitate a
stress response. Both perception and cognitive appraisal
are critical in this functioning, and information from the
pre-frontal cortex and frontal lobes (the decision making
and higher cognitive function centres of the brain) mediates
emotional, psychological, and behavioural outcomes. The
physiological and psychological pathways interrelate
closely, resulting in a stress cascade that involves both the
endocrine and autonomic nervous systems, thereby
incorporating a hormonal element. Interactions between
neurotransmitters, stress hormones, and negative effect of
these on the immune system resulting from
chronic/enduring stress, can alter the balance between
neurotransmitters [13].
With respect to cancer patients, both of these stress
pathways are pertinent. Somatic disease in itself may cause
physical stress reactions where pain or other symptoms
may give rise to severe distress. Furthermore, oncological
treatments frequently generate physiological stress through
excessive demand on the body by way of painful and often
invasive onco-therapeutic interventions. Psychological
stress appears to stem from the individual’s understanding
that the diagnosis implies a life-threatening disease and
having to live with its consequences. The symptoms of
cancer-specific stress include, inter alia, intrusive thoughts,
marked negative emotions towards cancer diagnoses, and
treatments together with avoidant cognitions and
behaviours. These symptoms of stress are all associated
with deficits in quality of life (QOL) and correlated with
poorer clinical outcomes, while in animal models of cancer
there is evidence that stress may decrease the effectiveness
of treatment or increase resistance to chemotherapeutic
agents [6,14].
Stress is considered a major precipitating psychological
issue for cancer patients from diagnosis through treatment
180

and prognosis, and even long after treatment has been
completed. It is a significant comorbidity as it is associated
with the growth and progression of disease and is closely
related to further psychological comorbidities such as
anxiety and depression [15]. Indeed, research indicates that
it is the chronicity of negative affect such as anxiety,
depressed mood, and/or hopelessness that appears to
correlate more strongly with outcomes than is true of
stressful events, suggesting that it is the prolonged arousal
of negative affective pathways that furnishes the strongest
association with disease progression through its effect on,
inter alia, tumour growth, angiogenesis and metastasis
[14,16]. Studies suggest that these stress-induced
neurobiological changes lead to significant impairment of
the immune system and prolonged anxious behavior
changes [14]. Mood disturbances, including depression
and anxiety, correlate highly with stress and, as such, mood
disturbance has been commonly used as an indicator of
stress [6].
Some research indicates that while initial stress
following a diagnosis of cancer tends to decrease over time,
a notable proportion of patients continue to experience
elevated levels of stress, sometimes for years after
successful completion of oncological treatment. In some
cases, patients may even go on to develop posttraumatic
stress disorder (PTSD) resulting from the cancer diagnosis,
indicating varying responses to the same stressor of cancer
diagnosis [6].
Body image disorders in breast cancer patients
Body image is widely acknowledged to be a critical
psychosocial issue for breast cancer patients and studies
show that the better the patient’s body image, the better is
the capacity to cope with cancer [17]. The construct of
body image is multidimensional and encompasses feelings,
perceptions, thoughts, and behaviors associated with the
whole body and how it functions [8]. It has been described
as a subjective picture the individual forms in her mind
regarding her own body, based on her observations of
herself and by judging what others think, based on their
reactions, with associated features such as emotional
expression, imitation, identification, ideals of beauty, and
social factors [17,19].
According to the Cash [20] cognitive-behavioural
model of body image, inherent in the concept of body
image is the notion of satisfaction or dissatisfaction with
one's body that is modified by two factors, appearance
investment and self‐evaluation. Appearance investment
refers to the individual's own view of the significance of
appearance and physical attributes, where self‐evaluation
refers to the contextual cultural ideals of beauty in physical
appearance, the degree to which the individual is satisfied
with her appearance, and whether there is dissonance
between the subjective perception of her physical
characteristics and the ideal characteristics. Since research
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suggests that the breast forms part of a woman's identity
and femininity and that women are socialized to perceive
that their personal value is bound up with their outward
appearance [21], it is clear that change or loss of a breast
will have a notable impact on the patient’s sense of her
body and its attractiveness.
Studies suggest that body image is closely correlated
with both psychological and physical symptoms including
identity, self‐esteem, perceptions of attractiveness, and
social interactions. Thus, body image disorders are
associated with poorer self‐esteem, increased social
anxiety, greater self‐consciousness, and depressive
symptoms and, furthermore, they are significantly related
to anxiety, fatigue, and fear of recurrence [17]. As such,
there exists a significant correlation between psychological
distress and poor body image [19].
Breast cancer therapy commonly results in adverse
effects with visible and nonvisible physiological impacts
(10). Patients receiving treatment for breast cancer are
exposed to significant changes in their appearance, such as
the loss or disfigurement of the breast, surgical scarring,
radiotherapy related skin changes and weight gain resulting
from systemic treatments. These changes are closely bound
to appearance and body image [19]. Upwards of 50% of
breast cancer survivors experience body image-related
concerns regarding both their body appearance and
function. Adjusting to these physiological changes is
challenging because treatment is demanding, both
physically and emotionally, and is associated with
increased psychopathology including anxiety and
depression. Research suggests that one in every three
breast cancer patients experiences chronic body-related
distress, such as fear of or shame regarding their altered
bodies, which disrupts attempts to resume normal life after
cancer [10].
In terms of age, younger women have been found to be
particularly at risk for psychological distress during and
after treatment since these women often have more
aggressive breast cancers and tend to attach greater
importance to their breasts in terms of their femininity and
sexuality [17]. Stage of treatment is an additional factor in
the development of body image disorders with some
studies suggesting that oncological treatment significantly
affects body image and the patient’s quality of life
immediately post-surgery and adjuvant treatment whereas
other research suggests that body image concerns only
emerge at a later time [22,23].

Materials and Methods
Participants
Convenience sampling was used to select participants
for this study. 80 female breast cancer patients and 80
female patients receiving treatment for other types of

cancer, (ovary, cervix, lung, and colon) were canvassed to
participate. All were patients at three oncology outpatient
treatment facilities within the Durban, Kwa-Zulu Natal,
South Africa area, receiving adjuvant chemotherapy or a
combination of chemo-and radiotherapy. Some had
previously undergone surgery. In order to meet the
inclusion criteria, participants had to be between the ages
of 30 and 70 years with no history of disease or other
comorbid conditions. The identified patients were
approached by the researcher and invited to take part in the
study of their psychological experiences during treatment.
The participants all provided written and oral consent
before taking part.
Materials
Participants meeting the inclusion criteria were given a
demographic questionnaire and a series of 4 questionnaires
to complete.
• Brief demographic questionnaire: a brief demographic
questionnaire detailing the participant’s age, marital status,
and medical history.
• The Beck Depression Inventory (BDI) [24]: This is a
widely-used, 21-item multiple-choice inventory measuring
attitudes and severity of depressive symptomatology.
Pertinent to the present study are items relating to
irritability, pessimism, feelings of guilt or being punished,
self-dissatisfaction, and social withdrawal, in addition to
physiological symptoms such as tiredness, weight loss, and
loss of libido. This inventory evaluates depression in
normal and psychiatric populations. Several items indicate
the presence of hopelessness and suicidal ideation. Items
are scored on a 4-point continuum, with the total score
range being 0–63. High scores point to more severe level
of depression.
• The Rosenberg Self-Esteem Scale [25]: This widelyused scale measures global self-esteem using a 10-item
Likert-type scale. It comprises a scale of 0–30, with a score
of less than 15 indicative of low self-esteem. Of the 10
items, five are positively worded statements and five are
negatively worded. This scale measures global self-worth
by means of measuring both positive and negative
perceptions of the self. It is considered reliable and valid
for the assessment of self-esteem
• The Stress Symptom Checklist (SSCL) [26]: This is an
87-item checklist relating to symptoms of unhealthy stress.
The intensity or severity of stress is measured as reported
by the patient’s reactions across 3 dimensions: physical (18
items), psychological (27 items), and behavioural (42
items). Each dimension is separately scored with a score of
three or more indicative of elevated stress. High scores
signify high levels of stress. The maximum score is 87. The
checklist allows for further interpretation, with scores of 8
and below indicative of low stress, mild stress ranging from
181
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9 to 15, moderate stress from 16 to 30, and the severe stress
from 31 to 45. Profound stress is reflected in scores of 46
and above. Moreover, the SSCL offers an indication as to
whether the respondent reflects stress reactions which are
mainly physical or psychological and/or behavioural in
nature. This scale is a useful clinical measure of stress.
•Body Image Scale (BIS) [18]: The BIS is a 10-item,
patient-reported outcome scale designed to briefly but
comprehensively rate 3 dimensions of body image, for use
exclusively with cancer patients: the affective (pertaining
to feelings such as self-consciousness), behavioural (for
example difficulties with looking at oneself naked) and
cognitive (level of satisfaction with appearance). There is
a 4-point response scale, the final score being the sum of
all 10 items, with a range of 0-30. Low scores signify fewer
symptoms and lower levels of body image distress while
higher scores are associated with more symptoms and
greater body image dysphoria.

Results
Data were analyzed using non-parametric tests as the
frequency of the scores was not normally distributed. The
Mann Whitney (two-sample Wilcoxon rank-sum test) was
used to compare differences between the breast and other
groups on the measures administered.
The BDI results suggest that no notable differences
exist between the breast and other group in terms of levels
of depression (p=0.3) and the measures of the majority of
patients fell within the minimal/mild range. Similarly, the
Rosenberg Self-esteem Scale showed no significant
differences between the breast and other group (p=0.2)
indicating that both groups reported similar measures of
self-esteem, with the majority of all the patients scores
falling within the low average range.
In terms of stress, according to the SSCL results, no
notable differences emerged between the groups on
measures of physiological reactions, however other
differences were apparent (Table 1).

Table 1. Results of SSCL: Psychological and behavioural responses.
Stress response

Breast

Other

Total

p-value

0.055

Psychological

n

%

n

%

<5

26

32.5

42

52.5

68

5-9

13

16.3

7

8.8

20

10-14

9

11.3

7

8.8

16

15-19

7

8.8

5

6.3

12

20-24

7

8.8

2

2.5

9

25-30

7

8.8

8

10.0

15

31-34

4

5.0

3

3.8

7

35-39

5

6.3

1

1.3

6

40-46

2

2.5

5

6.3

7

Total

80

100

80

100

<5

12

15.0

30

37.5

42

5-9

16

20.0

15

18.8

31

10-14

15

8.8

9

11.3

24

15-19

5

6.3

7

8.8

12

20-24

6

7.5

4

5.0

10

25-30

4

5.0

2

2.5

6

31-34

4

5.0

2

2.5

6

35-39

2

2.5

1

1.3

3

40-45

5

6.3

5

6.3

10

46-49

6

7.5

3

3.8

9

50-64

5

6.3

2

2.5

7

Total

80

100

80

100

Behavioural
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Although no notable differences emerged between the
two groups along physiological responses to stress,
significant differences in psychological (p=0.055) and
behavioural (p=0.002) manifestations of stress were found.
In terms of the psychological responses, the most notable
differences emerged on items related to feelings of tension
or being “keyed up” (p=0.007), low self-esteem (p=0.04),
and self-dislike (p=0.021), with the breast group reflecting
higher scores on these measures. Moreover, behavioural
responses yielded significant differences, in particular on
items relating to irritability (p=0.001), restlessness

(p=0.003), experiencing emotional outbursts frequently
(p=0.002), and difficulties with concentration (p=0.001),
with the breast cancer group again experiencing these
reactions more frequently. In sum, this suggests that
patients with breast cancer experience more severe
psychological and behavioural stress symptoms than do
patients with other sites of disease.
The results of the BIS also showed significant
differences between the breast and other group on several
items, with the breast group reflecting higher levels of body
image dissatisfaction on all items (Table 2).

Table 2. Results of the Body Image Scale
BIS item

response

1. Have you been feeling self-conscious
about your appearance?

Not at all
A little
Quite a bit
Very much
Not at all
A little
Quite a bit
Very much
Not at all
A little
Quite a bit
Very much
Not at all
A little
Quite a bit
Very much
Not at all
A little
Quite a bit
Very much
Not at all
A little
Quite a bit
Very much
Not at all
A little
Quite a bit
Very much
Not at all
A little
Quite a bit
Very much
Not at all
A little
Quite a bit
Very much
Not at all
A little
Quite a bit
Very much

2 Have you felt less physically
attractive as a result of your disease or
treatment?
3. Have you been dissatisfied with your
appearance when dressed?

4. Have you been feeling less feminine
as a result of your disease or treatment?

5. Did you find it difficult to look at
yourself naked?

6. Have you been feeling less sexually
attractive as a result of your disease or
treatment?
7. Did you avoid people because of the
way you felt about your appearance?

8. Have you been feeling the treatment
has left your body less whole?

9. Have you felt dissatisfied with your
body?

10. Have you been dissatisfied with the
appearance of your scar?

breast
n
15
32
15
18
22
29
19
10
33
31
9
7
37
26
10
7
44
21
7
8
20
33
14
13
42
24
11
3
29
35
9
7
27
29
15
9
42
23
9
6

%
18.8
40.0
18.8
22.5
27.5
36.3
23.8
12.5
4103
38.8
11.3
8.8
46.3
32.5
12.5
8.8
55.0
26.3
8.8
10.0
25.0
41.3
17.5
16.3
52.5
30
13.8
3.8
36.3
43.8
11.3
8.8
33.8
36.3
18.8
11.3
52.5
28.8
11.3
7.5

other
n
31
26
10
13
52
13
8
7
39
20
15
6
57
10
8
5
50
16
5
9
48
17
7
8
59
13
5
3
43
20
11
6
42
22
10
6
54
15
5
6

p-value
%
38.8
32.5
12.5
16.3
65.0
16.3
10.0
8.8
48.8
25.0
18.8
7.5
71.3
12.5
10.0
6.3
62.5
20.0
6.3
11.3
60.0
21.3
8.8
10.0
73.8
16.3
6.3
3.8
53.8
25.0
13.8
7.5
52.5
27.5
12.5
7.5
67.5
18.8
6.3
7.5

total
46
58
25
31
74
42
27
17
72
51
24
13
94
36
18
12
94
37
12
17
68
50
21
21
101
37
16
6
72
55
20
13
69
51
25
15
96
38
14
12

0.01

<0.001

0.71

0.01

0.44

0.001

0.01

0.11

0.02

0.08
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The most significant differences between the breast and
other groups emerge with respect to feelings of sexual
attractiveness (p=0.001) and physical attractiveness
(p=<0.001) as a result of the disease and treatment, with
the breast cancer group reporting significantly less
satisfaction with physical and sexual attractiveness. 52
respondents from the other group reported no problems
with feeling physically unattractive whilst only 22 patients
from the breast group had no difficulties with perceptions
of physical unattractiveness. With regard to feelings of
being sexually unattractive, 10% of the other group noted
extreme feelings of unattractiveness while 16.3% of the
breast group experienced marked feelings of sexual
unattractiveness attributed to the disease and treatment.
Further differences were found in terms of dissatisfaction
with one’s body (p=0.02), social avoidance resulting from
body dissatisfaction (p=0.01) and feeling less feminine
(p=0.01) as a result of disease and treatment. On all these
measures, the breast group scored consistently higher
results.
These findings correspond with the results of other
studies which have suggested that breast cancer and its
treatment engender higher levels of body image dysphoria
in patients than does disease in other sites.

Discussions
The principal goal of this study was the examination of
the psychological distress experienced by female breast
cancer patients and the identification of the differences in
psychological experience which these patients undergo,
with particular reference to expression of stress and issues
of body image. Since the literature widely shows that breast
patients experience elevated levels of stress and more
severe body image dysphoria when compared to patients
with other forms of disease, this study set out to determine
the accuracy of these findings.
In terms of stress, the results of the SSCL indicate that
breast cancer patients expressed their levels of stress postdiagnosis more through psychological and behavioural
responses than did the other group. Reactions such as
tension, low opinion of the self, and self-dislike emerged
as significant differences between the responses of the two
groups with the breast patients reporting experiencing
these more intensely. Similarly, in terms of behavioural
manifestations of stress, the breast group reported more
severe symptoms of irritability, restlessness, emotional
outbursts, and impaired ability to concentrate, symptoms
which are well described in the literature as being
associated with stress in breast patients [27]. Further,
features such as fearfulness, apathy, social isolation, and
difficulty with remembering and decision-making were
more marked in the breast group, confirming the results of
previous studies [28].
184

These results underscore that patients in the breast
group experienced stress more intensely and severely than
did patients in the general group, and through differential
means, suggesting that the experience of distress for these
patients differs in nature and severity to that of other
patients.
The findings here also confirm that breast patients
experience greater body image distress as reported on all
the items of the BIS, with significantly higher measures of
dysphoria in terms of physical and sexual attractiveness,
loss of feelings of femininity, and elevated levels of selfconsciousness, which yielded the most notable differences
between the two groups. Interestingly, while 22.5% of the
breast respondents reported intense feelings of selfconsciousness about their appearance, approximately half
of that number viz. 10.0% reported difficulties with
looking at themselves naked. Similarly, while 16.3% of the
breast group reported marked feelings of sexual
unattractiveness resulting from the disease and treatment,
only 8.8% reported notable negative effects on feelings of
femininity. Some studies have suggested that while selfconsciousness appears to be linked to a woman's identity,
her naked appearance is very closely associated with her
perception of her body. Moreover, the concept of
femininity is overarching and thus broader than sexual
attractiveness [29].
Research suggests that women are generally more
dissatisfied with the appearance of their bodies than are
men [30], and this tendency is exacerbated by the diagnosis
and treatment associated with oncology. Previous studies
have identified impairments in sexual attractiveness and
sexual intimacy as a critical issue for women in terms of
body image during their treatment, particularly those who
have undergone mastectomy and that self-consciousness
and dissatisfaction with their bodies have emerged as
impacting significantly on patients’ body image
perceptions [23]. A recent study has demonstrated further
body image issues, such as discomfort about self-image,
loss of confidence in body functioning, and avoiding
intimacy or exposing the physical self, as critical in these
patients. The same study found that grief expressions
relating to loss of function or of the perceived prior
attractive self were prevalent. In addition, the patients
feared being regarded as vain for articulating their body
image concerns, feeling they should feel gratitude for their
survival instead [31].
Therapeutic interventions
Optimal treatment of breast cancer-specific distress is
supportive and problem‐focused [32]. Education, control
of physical symptoms, and maintenance of effective and
inter-disciplinary communication constitute critical
factors.
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Studies suggest that various interventions may improve
patients’ coping with distress, improve their affect, and
reduce the negative effects of disease or treatment, thereby
improving their quality of life. Five types of intervention
were found to be effective, especially when used jointly:
education regarding the disease, behavioral training, for
example relaxation or yoga, cognitive-behavioral therapy
(CBT) including training in coping skills, stress
management skills, and support in professionally led or
group contexts [33].
Supportive‐expressive therapy is focused on current
life issues, challenges to optimal coping, and the
facilitation of expression of emotions. CBT is aimed at
helping patients to identify negative or irrational thoughts
they may have regarding themselves and their disease, to
examine how these thoughts lead to dysfunctional
behaviors and then guides the patient as to how to
assimilate more reasonable thoughts and more adaptive
behaviors [34]. CBT has been shown to positively affect
many psychological outcomes, particularly depression,
anxiety, and mood disorders [35]. CBT may include
coaching in relaxation techniques to alleviate stress,
psychoeducation, cognitive restructuring, and graduated
exposure to feared or unwanted thoughts and both CBT and
supportive expressive therapy have been shown to be
effective in reducing symptoms of psychological distress
in cancer patients [36,37]. A significant improvement in
QOL measures was observed in women receiving CBT on
an individual level [35]. A recent study found that an
exposure-based cognitive-behavioral
body image
intervention was successful in bringing about positive
changes in body image disturbance, with noted
improvements in related symptoms such as depression and
self-esteem [38].

Highlights
✓ Breast cancer patients experience psychological
distress differently as compared to patients with other
sites of disease.
✓ Specific body image disturbances and elevated stress
are prominent sequelae of breast cancer.
✓ The prevalence and severity of these comorbid
symptoms warrant closer observation of patients to
facilitate identification those at risk of distress.

Conclusions
This study was aimed at the examination of the
differential nature of psychological distress as experienced
by breast cancer patients in particular. It is broadly
acknowledged that breast cancer is a disease which
connotes unique comorbidities owing to the significance of
the breast as a sexual organ. These findings confirm
previous data in that, with respect to specifically body

image issues and stress, the patients were found to
experience elevated levels of distress as compared to
patients with cancers in other sites. The breast patient is
more vulnerable to feelings of impaired femininity, a
diminished perception of her sexual attractiveness, and a
tendency towards social avoidance resulting from
increased feelings of self-consciousness. Similarly, with
respect to the experience of stress, the breast patient
undergoes higher levels of psychological and behavioural
symptomatology, including tension, irritability and
restlessness.
These results indicate that both body image and stress
remain significant issues for the rising numbers of patients
undergoing adjuvant treatment for breast cancer. The goal
of oncology is not to merely extend survival intervals but
also to optimize the patient’s quality of life. While the
literature suggests that mental health issues are often
under-diagnosed and undertreated in oncology patients, it
is now clearly critical that healthcare professionals,
particularly those working in the field of oncology, become
more aware of the singular psychological issues facing
breast cancer patients in order to maximize their ability to
deliver quality care.
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